Amman Pharmaceutical Industries has a state of the art manufacturing plant which is located in Amman, Jordan with a total production space of around 5,000 m², and total laboratory space of around 500 m².
These facilities are dedicated to the development and production of both the company’s own products and others’ on a contract manufacturing or out-licensing basis and are comprised of the following divisions:
with an annual budget ranging 5% to 8% of our company’s revenues dedicated to research and development activities, Amman Pharmaceutical Industries has been able to fortify this vital division with the latest equipment, advanced tools, and brightest staff to fulfill the following activities:
Amman Pharmaceutical Industries is always investing in its production facilities and the continuous expansion of production lines and capacities. These facilities are capable of producing more than 100 million units per year in various forms and doses from the following sections:
state of the art labs that are dedicated to performing activities and tests of both Physical-chemical and Microbiological nature. Some of the tests performed before, during, and after production takes place are:
Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success.
